U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from MedGen

Items: 1 to 20 of 11665

1.
2023年第3版《NCCN肿瘤临床实践指南：非小细胞肺癌》更新解读
Lingling ZHU, Ting WANG, Juan WU, Xiaoqian ZHAI, Qiang WU, Hanyu DENG, Changlong QIN, Long TIAN, Qinghua ZHOU
Zhongguo Fei Ai Za Zhi. 2023 Jun 20; 26(6): 407–415. Chinese. doi: 10.3779/j.issn.1009-3419.2023.102.18
PMCID:
PMC10365961
AbstractArticlePDF–1.2M
2.
Antibody-Drug Conjugates as Novel Therapeutic Agents for Non-Small Cell Lung Carcinoma with or without Alterations in Oncogenic Drivers
Laura Bender Somme, Christos Chouaid, Fabien Moinard-Butot, Jean-Baptiste Barbe-Richaud, Laurent Greillier, Roland Schott
BioDrugs. 2024; 38(4): 487–497. Published online 2024 May 20. doi: 10.1007/s40259-024-00660-7
PMCID:
PMC11247051
AbstractArticlePDF–626K
3.
Small Cell Lung Carcinoma Cells Depend on KIF11 for Survival
Yuji Sakuma, Sachie Hirai, Miki Yamaguchi, Masashi Idogawa
Int J Mol Sci. 2024 Jul; 25(13): 7230. Published online 2024 Jun 30. doi: 10.3390/ijms25137230
PMCID:
PMC11241341
AbstractArticlePDF–4.3M
4.
Real‑world evidence of advanced non‑small cell lung carcinoma treated with an immune checkpoint inhibitor plus chemotherapy
Zihan Xu, Huien Zhang, Guikai Ma, Wenjuan Meng, Junliang Du, Xin Wu, Baohong Yang, Ningning Wang, Yanhong Ding, Qingyun Zhang, Na Li, Xuede Zhang, Guohua Yu, Shuzhen Liu, Zhenhua Li
Oncol Lett. 2024 Sep; 28(3): 405. Published online 2024 Jun 27. doi: 10.3892/ol.2024.14538
PMCID:
PMC11228919
AbstractArticlePDF–1.9M
5.
Artificial Intelligence and Machine Learning in Predicting the Response to Immunotherapy in Non-small Cell Lung Carcinoma: A Systematic Review
Tanya Sinha, Aiman Khan, Manahil Awan, Syed Faqeer Hussain Bokhari, Khawar Ali, Maaz Amir, Aneesh N Jadhav, Danyal Bakht, Sai Teja Puli, Mohammad Burhanuddin
Cureus. 2024 May; 16(5): e61220. Published online 2024 May 28. doi: 10.7759/cureus.61220
PMCID:
PMC11210434
AbstractArticlePDF–304K
6.
Deciphering fibroblast-induced drug resistance in non-small cell lung carcinoma through patient-derived organoids in agarose microwells
Qiyue Luan, Ines Pulido, Angelique Isagirre, Julian Carretero, Jian Zhou, Takeshi Shimamura, Ian Papautsky
Lab Chip. Author manuscript; available in PMC 2024 Jun 27.
Published in final edited form as: Lab Chip. 2024 Mar 26; 24(7): 2025–2038. Published online 2024 Mar 26. doi: 10.1039/d3lc01044a
PMCID:
PMC11209828
AbstractArticlePDF–1.7M
7.
Right eye metastasis of small‑cell lung carcinoma: A case report
Pei Zhu, Mingxing Wang, Qingming Sun, Wanhui Dong
Exp Ther Med. 2024 Aug; 28(2): 318. Published online 2024 Jun 14. doi: 10.3892/etm.2024.12607
PMCID:
PMC11208986
AbstractArticlePDF–4.0M
8.
Small cell lung carcinoma presenting initially with recurrent pneumothoraces: a case report
John Buchanan, Mohamed Shatila, Ashvini Menon, Akshay J. Patel
J Cardiothorac Surg. 2024; 19: 347. Published online 2024 Jun 21. doi: 10.1186/s13019-024-02857-x
PMCID:
PMC11191300
AbstractArticlePDF–936K
9.
A combined small cell lung carcinoma patient with only small cell carcinoma components in mediastinal lymph node metastasis and chondrosarcoma‐like components in liver metastasis
Takako Kawaguchi, Kei Yamasaki, Saki Shigemi, Hiroki Dosaka, Riho Hirosawa, Taiga Nagasawa, Satoshi Fujimoto, Shohei Shimajiri, Kazuhiro Yatera
Respirol Case Rep. 2024 Jun; 12(6): e01416. Published online 2024 Jun 20. doi: 10.1002/rcr2.1416
PMCID:
PMC11187537
AbstractArticlePDF–22M
10.
Multidrug-Resistant Profiles in Non-Small Cell Lung Carcinoma Patient-Derived Cells: Implications for Personalized Approaches with Tyrosine Kinase Inhibitors
Jelena Dinić, Miodrag Dragoj, Sofija Jovanović Stojanov, Ana Stepanović, Ema Lupšić, Milica Pajović, Thomas Mohr, Sofija Glumac, Dragana Marić, Maja Ercegovac, Ana Podolski-Renić, Milica Pešić
Cancers (Basel) 2024 Jun; 16(11): 1984. Published online 2024 May 23. doi: 10.3390/cancers16111984
PMCID:
PMC11171162
AbstractArticlePDF–3.8M
11.
KRAS as a Prognostic and Predictive Marker in Metastatic Non-Small Cell Lung Carcinoma: A Systematic Review
Sheereen Fatima, Nirav Pansuriya, Alisha Lakhani, Sai Madhuri, Reshma Ajmal, Ruchira Clementina, Zahabiya Lakdawala, Kinjal Shah, Husna Dilshana, Maya Andrea, Bejoi Mathew, Aashna Raheja
Cureus. 2024 May; 16(5): e60061. Published online 2024 May 10. doi: 10.7759/cureus.60061
PMCID:
PMC11162968
AbstractArticlePDF–374K
12.
Effects of methylation and transcription factor YY1 on ID2 expression in non-small cell lung carcinoma cells
Yi-Hsin Tseng, Wen-Ru Chou, Wei-Lun Liu, Zhong-Xuan Dung, Ching-Hao Lin, Chia-Hung Hsieh, Chi-Chung Wang
Am J Cancer Res. 2024; 14(5): 2424–2438. Published online 2024 May 15. doi: 10.62347/KXKL1421
PMCID:
PMC11162666
AbstractArticlePDF–1.7M
13.
Prognostic significance of pre B cell leukemia transcription factor 2 (PBX2) expression in non‐small cell lung carcinoma
Ying Qiu, Eiichi Morii, Yasuhiko Tomita, Binglin Zhang, Akihide Matsumura, Masanori Kitaichi, Meinoshin Okumura, Katsuyuki Aozasa
Cancer Sci. 2009 Jul; 100(7): 1198–1209. Published online 2009 Mar 12. doi: 10.1111/j.1349-7006.2009.01156.x
PMCID:
PMC11159276
AbstractArticlePDF–3.5M
14.
Role of interleukin‐17 in lymphangiogenesis in non‐small‐cell lung cancer: Enhanced production of vascular endothelial growth factor C in non‐small‐cell lung carcinoma cells
Xi Chen, Qichao Xie, Xiaoming Cheng, Xinwei Diao, Yue Cheng, Jiankun Liu, Wei Xie, Zhengtang Chen, Bo Zhu
Cancer Sci. 2010 Nov; 101(11): 2384–2390. Published online 2010 Sep 1. doi: 10.1111/j.1349-7006.2010.01684.x
PMCID:
PMC11159110
AbstractArticlePDF–732K
15.
The predictive value of delta-like3 and serum NSE in evaluating chemotherapy response and prognosis in patients with advanced small cell lung carcinoma: An observational study
Chenghua Zhu, Jianling Huang, Xiao Jin, Changwen Zhang, Changjun Zhu, Minjie Lv, Sixi Chen, Xingran Du, Ganzhu Feng
Medicine (Baltimore) 2024 Jun 7; 103(23): e38487. Published online 2024 Jun 7. doi: 10.1097/MD.0000000000038487
PMCID:
PMC11155540
AbstractArticlePDF–739K
16.
Tumor-Induced Osteomalacia due to Sarcomatoid Non–Small Cell Lung Carcinoma Confounded by Drug-Induced Fanconi Syndrome
Bassam AlHamer, Ajit Singh, Carmen Patrascu, Mona Al Mukaddam
JCEM Case Rep. 2024 Jun; 2(6): luae101. Published online 2024 May 30. doi: 10.1210/jcemcr/luae101
PMCID:
PMC11137757
AbstractArticlePDF–482K
17.
Osimertinib Resistance via Histologic Transformation From Non-small Cell Lung Carcinoma to Carcinosarcoma
Paul Stegelmeier, James A Dawson, McKenzie Wallace, Magda Esebua
Cureus. 2024 Apr; 16(4): e59293. Published online 2024 Apr 29. doi: 10.7759/cureus.59293
PMCID:
PMC11135651
AbstractArticlePDF–576K
18.
Impact of concurrent medications on the outcome of immunotherapy in non‐small cell lung carcinoma
Jun Yamada, Takafumi Fukui, Atsuhiko Yatani, Chihiro Mimura, Kiyoko Fukuda, Daisuke Hazama, Naoko Katsurada, Tatsuya Nagano, Masatsugu Yamamoto, Motoko Tachihara
Thorac Cancer. 2024 May; 15(15): 1228–1236. Published online 2024 Apr 15. doi: 10.1111/1759-7714.15294
PMCID:
PMC11128370
AbstractArticlePDF–947K
19.
Double Whammy: Abscopal Effect and Pseudoprogression in a Case of Non-small Cell Lung Carcinoma With Brain Metastases
Pranjal Rai, Abhishek Mahajan, Shreya Shukla, Ujjwal Agarwal
Cureus. 2024 Apr; 16(4): e59099. Published online 2024 Apr 26. doi: 10.7759/cureus.59099
PMCID:
PMC11128365
AbstractArticlePDF–1.2M
20.
Non‐small cell lung carcinoma with focal coexpression of thyroid transcription factor‐1 and Δ Np63/p40: A case report
Kazuhiro Terada, Toshi Menju, Horoshi Date, Hironori Haga, Akihiko Yoshizawa
Thorac Cancer. 2024 Apr; 15(12): 1029–1033. Published online 2024 Mar 13. doi: 10.1111/1759-7714.15271
PMCID:
PMC11045332
AbstractArticlePDF–1.0M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center